Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal
of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis …

STUDY QUESTION How should endometriosis be diagnosed and managed based on the
best available evidence from published literature? SUMMARY ANSWER The current …

According to consistent epidemiological data, the slope of the incidence curve of
endometriosis rises rapidly and sharply around the age of 25 years. The delay in diagnosis …

Abstract BACKGROUND The Endometriosis Health Profiles (EHPs), the EHP-30 and EHP-5,
are patient-reported outcome measures that were developed to measure the health-related …

This work provides consensus guidance regarding clinical diagnosis and early medical
management of endometriosis within Asia. Clinicians with expertise in endometriosis …

Endometriosis is a chronic disease that requires a suitable, lifelong treatment. To our
knowledge, the Vi sanne P ost-approval O bservational S tudy (VIPOS) is to date the largest …

ABSTRACT Study Objective To determine whether dienogest therapy after endometriosis
surgery reduces the risk of endometriosis recurrence compared with expectant …

To err is human and we all make mistakes, but this simple truth is not a satisfactory excuse
for many of our affected patients, especially in developed countries. Despite the fact that …

Several clinical trials in women with endometriosis demonstrated that dienogest reduces
endometrial lesions and improves health-related quality of life (HRQoL). To assess HRQoL …

Background: Dienogest is a progestin with demonstrated efficacy in the treatment of
endometriosis in European women. The objective of this study was to evaluate the efficacy …